Skip to main content

Table 2 Scenarios explored for designs when simulating operating characteristics

From: Bayesian group sequential designs for phase III emergency medicine trials: a case study using the PARAMEDIC2 trial

 

Placebo survival rate

Adrenaline survival rate

30-day survival rate 6%

6%

6%

7%

6%

6%

7%

8%

6%

6%

8%

30-day survival rate 3%

3%

3%

4%

3%

3%

4%

5%

3%

3%

5%

30-day survival rate 2%

2%

2%

3%

2%

2%

3%

4%

2%

2%

4%